Health Catalyst (HCAT) CEO Albert Benjamin Sells 321 Shares

What Happened Albert Benjamin, CEO and director of Health Catalyst (HCAT), had 321 shares sold at $1.70 per share on September 1, 2026, generating $547. This was a sell-to-cover transaction to satisfy tax withholding tied to the vesting of restricted stock units (RSUs), not an open-market discretionary sale.

Key Details

• Transaction date and price: 2026-09-01 — 321 shares sold at $1.70 per share (total $547).
• Transaction type/code: F — sale to cover tax withholding obligations on RSU vesting.
• Shares owned after transaction: Not specified in the provided filing summary.
• Footnote: The sale was mandated to cover tax withholding required by the issuer’s equity plan; it was not a discretionary trade by the reporting person.
• Filing timeliness: Form filed 2026-09-03 (appears timely within the typical two-business-day reporting window).

Context

• Sell-to-cover transactions are routine administrative sales when RSUs vest and taxes are due; they do not necessarily signal a view on the company’s prospects.
• For retail investors, purchases or voluntary sales by insiders may carry more interpretive weight than mandatory tax-withholding disposals.